ABS TRA CT The present study examined the effect of prostaglandin El (PGE1) on renal water excretion in the anesthetized dog. Renal perfusion pressure was kept constant by adjustment of a suprarenal aortic clamp. In seven experiments the intravenous administration of PGE1 (7 /Lg/min) significantly increased urinary osmolality from 76 to 381 mosmol (P < 0.001) and decreased free water clearance from 2.2 to -0.02 ml/ min (P < 0.001). These effects promptly were reversed with cessation of the infusion. This antidiuretic effect occurred both in innervated and denervated kidneys and was not associated with changes in glonmerular filtration rate, renal vascular resistance, or solute excretion rate. In 10 experiments in hypophysectomized dogs no effect of intravenous PGE1 on free water clearance and urinary osmolality was observed. The intrarenal administration of PGE1 (1 Ag/min) to six water-loaded and two hypophysectomized dogs caused no systemic vascular changes and increased rather than decreased free water clearance (2.83 to 4.08 ml/min, P < 0.001). No significant change in urinary osmolality occurred. Glomerular filtration rate was not altered by the intrarenal infusion, but reversible changes in solute excretion rate and renal vascular resistance occurred. These results thus indicate that the antidiuresis associated with intravenous PGE1 is mediated primarily by the release of vasopressin rather than alterations in renal hemodynamics or solute excretion. The diuretic effect of intrarenal PGE1 occurs in the absence of vasopressin and is most likely medi-A preliminary report of this work was presented at the
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INTRODUCTION
The prostaglandins, a group of naturally occurring fatty acids, have been implicated in the regulation of hormonal action in various tissues. The results of in vitro studies in the toad bladder (1, 2) and the rabbit collecting duct (3) indicate that prostaglandin El (PGE,)' may antagonize the hydro-osmotic effects of vasopressin. PGE1 has also been found to inhibit the vasopressin-mediated changes in adenyl cyclase activity and 3',5'-adenosine monophosphate (cyclic AMP), thereby providing an explanation for the mechanism whereby PGE1 may antagonize the in vitro effect of vasopressin on osmotic water movement (4) . In the absence of vasopressin, an in vitro effect of PGE1 has not been observed on water movement in the toad bladder (1) but PGEi has been reported to enhance water movement in the rabbit collecting duct (3) .
The in vivo effects of PGE1 on renal water excretion in the mammalian nephron have been less intensely investigated. Infusion of PGE1 into the renal artery of the dog has been reported to increase free water clearance (5-7), but whether the presence of vasopressin is necessary for such an effect to occur has not been defined. In contrast to this diuretic effect of intrarenal PGE1, the infusion of PGE, intravenously may be associated with an antidiuresis (8) . Whether such an antidiuretic effect occurs as a result of the endogenous release of vasopressin (ADH), alterations in systemic and renal hemodynamics or a primary effect of the agent on the water permeability of the collecting duct is not known. The present investigation was therefore undertaken to investigate the mechanisms whereby PGE1 may alter renal water excretion in the mammalian nephron. Intravenous infusion of PGE1 was found to produce an antidiuresis which could be dissociated from a diminution in renal perfusion pressure, renal hemodynamics, or solute excretion rate and could be abolished by acute hypophysectomy. The intrarenal infusion of prostaglandin, in an amount comparable to that reaching the kidney during the intravenous infusion, was never associated with such an antidiuresis, but rather increased free water excretion even in the absence of endogenous vasopressin. This increase in free water excretion occurred without significant alterations in urinary osmolality and appeared to be primarily related to increased delivery of tubular fluid to the diluting segment of the nephron. (9) . After completion of the above surgery an intravenous infusion of a 0.9% sodium chloride solution (0.5 ml/min) was started containing sufficient inulin and p-aminohippuric acid to maintain levels between 15-20 mg/ 100 ml and 1-3 mg/100 ml, respectively. If 30 min after the infusion of the liter of 2.5%o g/100 ml glucose, the urinary osmolality of any animal was above 150 mosmol/kg, an additional 600 ml of 2.5 g/100 ml glucose was administered over 20 min. Thereafter, the infusion rate was decreased to 4 ml/min above urine flow. Experiments were only performed in those animals in which urine osmolality was below 150 mosmol/kg. In these animals the experiments were started after the urine flow rate had stabilized for 30 min. Throughout the experiment the periods of urine collection were 5-10 min in duration and arterial and renal venous blood samples were obtained at the midpoint of alternate urine collections. Cardiac outputs were measured every third period. Intrarenal prostaglandin E studies (Fig. 4 , Table   III ). In the intrarenal studies one-seventh of the i.v.
dose of PGEi was infused directly into the renal artery. equal the amount of the drug reaching the renal circulation during the i.v. studies. The intrarenal infusion of this dose of PGE2 was not associated with any of the systemic hemodynamic effects which occurred during the i.v. studies (Table III) . The arterial pressure, cardiac output, and total peripheral resistance were not significantly different before, during, or after intrarenal PGEi. The deficiency of endogenous vasopressin in these studies seemed documented by the control level of U0.. of 67±7 mosmol/kg. In addition, exps. 7 and 8 were performed in acutely hypophysectomized animals undergoing a water diuresis. The intrarenal infusion of PGE1 was associated with an increase in CH-O from 2.83±0.4 to 4.08±0.5 ml/min (P < 0.001) in the infused kidney, which decreased to 2.24±0.5 ml/min (P < 0.001) after cessation of the PGE1 infusion. At the same time the mean C3920 in the contralateral kidneys was 1.83±0.3 ml/min before, 1.56±0.3 ml/min during, and 1.44±0.3 ml/min after the infusion of PGE,. The Uos. in the infused kidneys was 67+7, 67+7, 87+14 mosmol/kg before, during, and after the infusion of PGE1 and at the same time was 83+11, 94±13, 98±13 mosmol/kg in the contralateral kidney. None of the values for U.os. and CH20 were significantly different in the contralateral kidney. The changes in CHs2o in the infused kidney were significantly different as was the increase in Uosm which occurred after cessation of the infusion (P < 0.05).
The individual values for U0.m and CH0o in the infused and noninfused kidney are shown in Fig. 4 . The increase in CH20 in the infused kidney was associated with a significant decrease in RVR and FF, and an increase in GFR. While the RVR and FF increased significantly after cessation of the PGE1 infusion the GFR was unchanged. The intrarenal PGE1 was also associated with a significant increase in urinary sodium and potassium excretion and osmolar clearance in the infused kidney. There was no change in renal hemodynamics or electrolyte excretion in the contralateral kidney except for an increase in GFR during the PGE, infusion which was not reversible after cessation of the infusion.
DISCUSSION
The present investigation was undertaken to examine the mechanisms whereby PGE1 may affect renal water excretion in the mammalian nephron. The results demonstrate that PGE1 may exert divergent effects on renal water excretion depending on the dose and route of administration. The i-v. administration of PGE1 was consistently associated with an antidiuresis which occurred independent of changes in renal perfusion pressure, renal hemodynamics, renal innervation, and changes in solute excretion rate (Fig. 1, Table I ). as the level of urinary osmolality remained in a range compatible with maximal suppression of vasopressin release and impermeability of the collecting duct. The increase in free water clearance therefore seemed to be related to an increased delivery of tubular fluid to the diluting segment of the nephron. Since the alterations in GFR were comparable in the infused and noninfused kidneys, a depression in proximal tubular fluid reabsorption may have been primarily responsible for the increased distal delivery of tubular fluid in the infused kidney.
In qualitative terms, the effect of intrarenal PGE1
to increase free water clearance in the present animals undergoing a water diuresis was similar to previous observations in hydropenic animals (5-7). On the basis of the present results it therefore seems reasonable to conclude that at least part of the effect of PGE1 to increase water excretion in hydropenic animals must be related to increased delivery of tubular fluid to the diluting segment of the nephron rather than any direct antagonism of the action of vasopressin. The present results should not, however, be taken to exclude an additional inhibitory effect of PGEi on the action of vasopressin. The results during i.v. PGE1 do, however, suggest that if such an inhibitory effect occurs it can be overcome by the effect of i.v. PGE1 to increase the endogenous release of vasopressin. Studies designed to demonstrate such an inhibitory effect of PGEL on the action of vasopressin in vivo must therefore avoid the extrarenal effects of the drug to release vasopressin, as well as the intrarenal effects of the PGEi to increase the delivery of tubular fluid to the distal diluting segment. In the present study the dose of PGEi infused into the renal artery caused no systemic vascular effects, but intrarenal hemodynamic alterations were consistently observed. In the presence of such renal vascular effects of PGE1 any in vivo effect on renal water excretion cannot be attributed to an antagonism of the action of vasopressin (5-7 
